OBJECTIVE: The Face-Name Associative Memory Examination (FNAME) is a cross-modal associative memory test with a high sensitivity for detecting Alzheimer's disease-related subtle memory problems at an early preclinical stage. The present study examined the psychometric characteristics of a Greek version of the short form of FNAME (GR-FNAME12) to evaluate the contribution of demographic characteristics, report the range of performance within our sample, and estimate regression-based norms in cognitively normal elderly individuals. METHOD: In all, 216 cognitively normal elderly individuals were recruited and were administered a version of the short form of the FNAME (GR-FNAME12) that was culture and language specific to Greek-speaking individuals and developed for this study. RESULTS: The construct validity of GR-FNAME12 was determined using principal component analysis thereby revealing two factors: face-name and face-occupation. These match the original version of the test. A significant positive correlation between GR-FNAME12 and two traditional memory measures - the RAVLT and the ROCFT - supported convergent validity. Test-retest reliability was computed for 32 participants. Multiple regression analyses showed that only age and not education or gender significantly predicted performance on the GR-FNAME12. We also estimated regression-based norms for the GR-FNAME12 scales. CONCLUSION: It was found that the Greek version of the FNAME12 had adequate psychometric properties, and could be administered to Greek-speaking individuals for clinical and research purposes.
OBJECTIVE: The Face-Name Associative Memory Examination (FNAME) is a cross-modal associative memory test with a high sensitivity for detecting Alzheimer's disease-related subtle memory problems at an early preclinical stage. The present study examined the psychometric characteristics of a Greek version of the short form of FNAME (GR-FNAME12) to evaluate the contribution of demographic characteristics, report the range of performance within our sample, and estimate regression-based norms in cognitively normal elderly individuals. METHOD: In all, 216 cognitively normal elderly individuals were recruited and were administered a version of the short form of the FNAME (GR-FNAME12) that was culture and language specific to Greek-speaking individuals and developed for this study. RESULTS: The construct validity of GR-FNAME12 was determined using principal component analysis thereby revealing two factors: face-name and face-occupation. These match the original version of the test. A significant positive correlation between GR-FNAME12 and two traditional memory measures - the RAVLT and the ROCFT - supported convergent validity. Test-retest reliability was computed for 32 participants. Multiple regression analyses showed that only age and not education or gender significantly predicted performance on the GR-FNAME12. We also estimated regression-based norms for the GR-FNAME12 scales. CONCLUSION: It was found that the Greek version of the FNAME12 had adequate psychometric properties, and could be administered to Greek-speaking individuals for clinical and research purposes.
Entities:
Keywords:
FNAME; cross-cultural neuropsychology; preclinical Alzheimer’s disease; regression-based norms; test construction
Authors: Constantinos Kormas; Ioannis Zalonis; Ioannis Evdokimidis; Elisabeth Kapaki; Constantin Potagas Journal: Front Aging Neurosci Date: 2019-07-23 Impact factor: 5.750
Authors: Valentina Gallo; Damien M McElvenny; Giulia Seghezzo; Simon Kemp; Elizabeth Williamson; Kirsty Lu; Saba Mian; Laura James; Catherine Hobbs; Donna Davoren; Nigel Arden; Madeline Davies; Andrea Malaspina; Michael Loosemore; Keith Stokes; Matthew Cross; Sebastian Crutch; Henrik Zetterberg; Neil Pearce Journal: Alzheimers Dement Date: 2021-10-20 Impact factor: 16.655
Authors: Kirsty Lu; Jennifer M Nicholas; Jessica D Collins; Sarah-Naomi James; Thomas D Parker; Christopher A Lane; Ashvini Keshavan; Sarah E Keuss; Sarah M Buchanan; Heidi Murray-Smith; David M Cash; Carole H Sudre; Ian B Malone; William Coath; Andrew Wong; Susie M D Henley; Sebastian J Crutch; Nick C Fox; Marcus Richards; Jonathan M Schott Journal: Neurology Date: 2019-10-30 Impact factor: 9.910